Jove
Visualize
Contact Us

Related Experiment Videos

Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy.

G T Carter1, C M McDonald

  • 1Department of Rehabilitation Medicine, School of Medicine, University of Washington, Seattle, USA.

American Journal of Physical Medicine & Rehabilitation
|September 20, 2000
PubMed
Summary

This case study suggests long-term intermittent pulse prednisone may preserve skeletal muscle function in Duchenne muscular dystrophy (DMD). The patient remained ambulatory longer than his untreated uncle with DMD.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zinc and multivitamin supplementation have contrasting effects on infant iron status: a randomized, double-blind, placebo-controlled clinical trial.

European journal of clinical nutrition·2017
Same author

Waist-to-Height Ratio as an Indicator of High Blood Pressure in Urban Indian School Children.

Indian pediatrics·2015
Same author

Association of oral iron supplementation with birth outcomes in non-anaemic South Indian pregnant women.

European journal of clinical nutrition·2014
Same author

Household food insecurity and dietary diversity as correlates of maternal and child undernutrition in rural Cambodia.

European journal of clinical nutrition·2014
Same author

Predictors of stunting, wasting and underweight among Tanzanian children born to HIV-infected women.

European journal of clinical nutrition·2012
Same author

Prospectively surveying health-related quality of life and symptom relief in a lot-based sample of medical cannabis-using patients in urban Washington State reveals managed chronic illness and debility.

The American journal of hospice & palliative care·2012
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neurology
  • Pulmonology
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) is a progressive genetic disorder characterized by muscle degeneration.
  • Asthma exacerbations can complicate management and impact quality of life in DMD patients.
  • Current treatments for DMD offer limited efficacy in halting disease progression.

Observation:

  • A patient with DMD received intermittent pulse prednisone for severe asthma from age 3 to 17.
  • This treatment regimen resulted in remarkable preservation of skeletal muscle function.
  • The patient remained partially ambulatory at age 20, unlike his untreated uncle who died at 19 from respiratory failure.

Findings:

  • Long-term, intermittent pulse prednisone therapy appears to offer significant clinical benefit in preserving skeletal muscle function in DMD.

Related Experiment Videos

  • The observed benefit in this case suggests a potential disease-modifying effect beyond asthma control.
  • Comparison with an affected uncle with identical mutation highlights the potential impact of prednisone treatment.

    • Implications:

    • This case provides anecdotal evidence supporting extended use of pulse prednisone in DMD management.
    • Further clinical investigation is warranted to explore the efficacy and safety of long-term pulse prednisone therapy in DMD.
    • This approach may offer a novel therapeutic strategy to improve functional outcomes and longevity in DMD patients.